....Isn't the Sony petasite( sp?) a 19mm helical scan format?
1/2" DTF.....DTF2 (24 MB/s + 100 GB) due later this year.......Sony also has a 19mm tape drive that competes with DST......
bpgprod.sel.sony.com
I agree with you about the value of partitioning. Check out some of the drivers of storage demand for the next century.
BIG IDEAS THAT WILL CHANGE THE WORLD
globalprovince.com
3.Cellular Neural Networks or Cellular Non-Linear Networks
These are not neural networks, but something different. Scientists from Berkeley to Hungary have teamed together to make it possible to translate complex visual images to your computer screen on a real-time basis. This involves a mix of algorithms, special new microchips, old-fashioned analog computers, and linkages to the digital world. The applications include everything from night vision to medical imaging. See The Economist, March 6, 1999, page 74, "Analogue Computing Looking Good." For more data, contact Mr. Philip F. Otto, TeraOps, e-mail: otto@teraops.com..
2. Patient-Friendly Information on Critical Diseases
Health costs are still rising and the quality of patient care continues to decline. The whole effort in the patient information systems area promises to break this Gordian knot. Particularly the offerings from Fairview Medical. Its Health Dialog taps the best clinical database in the country, putting the information in patient-friendly form and delivering it to the patient in a variety of ways. Fairview works through large healthcare groups to make its service affordable and usable by patients with critical problems. It believes that fully-informed patients with the best data will make the best medical decisions, raising the quality of their care as well as averting unnecessary costs and procedures. To read more, see The Wall Street Journal, April 22, 1998, "New Videos Arm Patients With Power of Information." For more information, look at Fairview's website at healthdialog.com.
1. Gene Sequencing
The race is on. The government is trying to do a gene map of our bodies in its Human Genome Project at the National Center for Human Genome Research. Meanwhile, Celera Genomics, part of Perkin-Elmer, led by J. Craig Venter, is seeing if it can beat the Government to the punch. When this is done, drug companies will be able to invent drugs that target diseases more forcibly while avoiding many of the side effects produced by our current batch of drugs. All our treatments for cancer, for instance, are still terribly crude and will be until we truly have drugs with biotech bite that will clobber errant cancer cells. We're finally doing in the gene world what we did in the 1930's and 1940's in the atomic world.
This race indicates that we need more competition in scientific research. And asks us to figure out what R&D gets done best by the government/university complex as opposed to private skunkworks. It's not clear. Many, many developments only get off the ground under government auspices, but the pace is always a bit slow. How do we get our governments to develop their own limited-life skunkworks? To read more, see The Wall Street Journal, March 11, 1999, page B5, "Gene-Sequencing Race Between U.S. and Private Researchers is Accelerating." For more, see Perkin-Elmer website at perkin-elmer.com.
In addition to The Human Genome Project and Celera Genomics, a new consortium was formed last week.
dailynews.yahoo.com
....Also involved are AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Company (NYSE:BMY - news), Roche Holding AG, Glaxo Wellcome Plc, Hoechst AG (NYSE:HOE - news), Pfizer Inc (NYSE:PFE - news), Monsanto's pharma unit Searle and SmithKline Beecham, as well as academic centers and Britain's Wellcome Trust.... |
